Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Introduction; reception must be understood as the offered attention within the relationship between a healthcare worker and the patient, including attitudes of inclusion, hearing, valorization of complains and identification of needs, being these individual collective. As a part of this process, communication is a primary and indispensable toll through which the healthcare team and the patient interchange information.
Objective: to evaluate the influence of perception of patients suffering of knee osteoarthritis over fear, catastrophizing of pain and effectiveness, related to intra-articular injection od corticosteroids.
Material and method: it will be performed a prospective, controlled and randomized study eith a blind evaluator on patients with symptomatic knee osteoarthritis submitted to joint injection. A hundred patients suffering of symptomatic knee osteoarthritis coming from the outpatient area of Rheumatology Division of Federal University of Sao Paulo (UNIFESP) will be evaluated, 50 belonging to the intervention group (reception) and 50 to a control group.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention Group | Experimental | Patients will receive the reception treatment before the joint injection |
|
| Control Group | Active Comparator | patient will receive a joint injection |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Reception | Procedure |
| ||
| Joint injection with triamcinolone hexacetonide |
| Measure | Description | Time Frame |
|---|---|---|
| Change on pain | Pain will be evaluated with an visual analogue scale | baseline, after 1, 4 and 12 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Change on functional capacity | functional capacity will be evaluated with Health assesment questionary (HAQ) | baseline, after 1, 4 and 12 weeks |
| Change on Catastrophizing | Catastrophizing will be evaluated with an Catastrophizing test |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Sandra R Toffolo, Msc nurse | Contact | 551155764239 | s-regina-toffolo@bol.com.br | |
| Rita NV Furtado, PhD MD | Contact | 551155764239 | rvfurtado@hotmail.com |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D020370 | Osteoarthritis, Knee |
| ID | Term |
|---|---|
| D010003 | Osteoarthritis |
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D007270 | Injections, Intra-Articular |
| C005900 | triamcinolone hexacetonide |
| ID | Term |
|---|---|
| D007267 | Injections |
| D004333 | Drug Administration Routes |
| D004358 | Drug Therapy |
| D013812 | Therapeutics |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Drug |
joint injection with corticosteroids |
|
| baseline, after 1, 4 and 12 weeks |
| Change on functional capacity | functional capacity will be evaluated with the time to up and go test | baseline, after 1, 4 and 12 weeks |
| D012216 |
| Rheumatic Diseases |